ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frazier, O. H.
Right arrow Articles by Fuqua, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frazier, O. H.
Right arrow Articles by Fuqua, J. M.

The Annals of Thoracic Surgery, Vol 49, 299-304, Copyright © 1990 by The Society of Thoracic Surgeons


ARTICLES

First human use of the Hemopump, a catheter-mounted ventricular assist device

OH Frazier, RK Wampler, JM Duncan, WE Dear, MP Macris, SM Parnis and JM Fuqua
Cullen Cardiovascular Surgical Research Laboratories, Texas Heart Institute/St. Luke's Episcopal Hospital, Houston 77225.

The Hemopump, a catheter-mounted, temporary ventricular assist device, consists of an external electromechanical drive console and a disposable, intraarterial axial-flow pump (21F). Power is transmitted percutaneously to the pump by a flexible drive shaft within the catheter. The device is positioned in the left ventricle by way of the femoral artery approach or through the ascending aorta. Blood is drawn from the left ventricle through the transvalvular inlet cannula and pumped into the aorta. As of December 1988, the Hemopump had successfully supported the circulation of 7 patients (5 men, 2 women) ranging in age from 44 to 72 years (mean age, 59 years) and suffering from cardiogenic shock (cardiac index less than 2.0 L/min/m2). Indications for use included failure to be weaned from cardiopulmonary bypass in 4 patients, acute myocardial infarction in 1, severe cardiac allograft rejection in 1, and donor heart failure in 1. Duration of support ranged from 26 to 113 hours (mean, 66 hours). Although 5 patients demonstrated transient hemolysis, none experienced infection, thrombosis, or vascular injury. Hemodynamic variables improved in all patients during support by the device. As of December 1988, 5 of the 7 patients were alive more than 30 days after support had been discontinued, and 3 of these patients were discharged from the hospital. On the basis of our initial clinical results, the Hemopump, which does not require a major surgical procedure for insertion, provides effective, temporary circulatory support in patients with potentially reversible cardiac failure.


This article has been cited by other articles:


Home page
CirculationHome page
D. A. Cooley
Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist System
Circulation, June 18, 2002; 105(24): 2808 - 2809.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Sweeney
The Hemopump in 1997: a clinical, political, and marketing evolution
Ann. Thorac. Surg., August 1, 1999; 68(2): 761 - 763.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. Lonn, B. Peterzen, B. Carnstam, and H. Casimir-Ahn
Beating heart coronary surgery supported by an axial blood flow pump
Ann. Thorac. Surg., January 1, 1999; 67(1): 99 - 104.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
N. G. Smedira, C. C. Hlozek, and P. M. McCarthy
Mechanical Support After Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 66 - 77.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. Lonn, J. Wulff, K.-Y. Keck, B. Wranne, P. Ask, B. Peterzen, and H. Casimir-Ahn
Flow Characteristics of the Hemopump: An Experimental In Vitro Study
Ann. Thorac. Surg., January 1, 1997; 63(1): 162 - 166.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
B. Peterzen, U. Lonn, A. Babic, H. Granfeldt, H. Casimir-Ahn, and H. Rutberg
Postoperative Management of Patients With Hemopump Support After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., August 1, 1996; 62(2): 495 - 500.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. D. Dreyfus
Hemopump 31, the Sternotomy Hemopump: Clinical Experience
Ann. Thorac. Surg., January 1, 1996; 61(1): 323 - 328.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
U. Lonn, B. Peterzen, H. Granfeldt, A. Babic, and H. Casimir-Ahn
Hemopump Treatment in Patients With Postcardiotomy Heart Failure
Ann. Thorac. Surg., October 1, 1995; 60(4): 1067 - 1071.
[Abstract] [Full Text]


Home page
PerfusionHome page
T. McCarthy and D. Wheeldon
Long-term blood pumping: an overview
Perfusion, May 1, 1995; 10(3): 143 - 151.
[PDF]


Home page
Ann. Thorac. Surg.Home page
G. J. Cooper, D. Y. Loisance, M. Miyama, Y. Abe, and P. H. Deleuze
Direct Mechanical Assistance of the Right Ventricle With the Hemopump in a Porcine Model
Ann. Thorac. Surg., February 1, 1995; 59(2): 443 - 447.
[Abstract] [Full Text]


Home page
J Biomater ApplHome page
A. A. Lefemine and J. Dunbar
Simple Alternatives Using a Single Centrifugal Pump for Biventricular Assistance in Cardiogenic Shock
J Biomater Appl, April 1, 1990; 4(4): 333 - 361.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.